Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)
Identifiers
Symbols	SPP1; BNSP; BSPI; ETA-1; MGC110940; OPN
External IDs	OMIM: 166490 MGI: 98389 HomoloGene: 20156
Gene ontology Molecular function • cytokine activity • integrin binding • protein binding Cellular component • extracellular region • proteinaceous extracellular matrix • extracellular space • apical part of cell Biological process • ossification • anti-apoptosis • cell adhesion • cell-matrix adhesion • negative regulation of bone mineralization
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	6696	20750
Ensembl	ENSG00000118785	ENSMUSG00000029304
UniProt	P10451	Q3TND2
RefSeq	NM_000582 (mRNA)	NM_009263 (mRNA)
	NP_000573 (protein)	NP_033289 (protein)
Location	Chr 4: 89.12 - 89.12 Mb	Chr 5: 104.68 - 104.68 Mb
PubMed search	[1]	[2]

Secreted phosphoprotein 1 (SPP1), also known as bone sialoprotein I (BSP-1), early T-lymphocyte activation (ETA-1), and most commonly as osteopontin (OPN), is a human gene product,^[1] which is also conserved in other species. Osteopontin is a glycoprotein that was first identified in 1986 in osteoblasts. The prefix of the word "osteo" indicates that the protein is expressed in bone, although it is also expressed in other tissues. The suffix "-pontin" is derived from "pons," the Latin word for bridge, and signifies osteopontin's role as a linking protein. Osteopontin is an extracellular structural protein and therefore an organic component of bone. Synonyms for this protein include sialoprotein I and 44K BPP (bone phosphoprotein).

The gene has 7 exons, spans 5 kilobases in length and in humans it is located on the long arm of chromosome 4. The protein is composed of ~300 amino acids residues and has ~30 carbohydrate residues attached including 10 sialic acid residues, which are attached to the protein during post-translational modification in the Golgi apparatus. The protein is rich in acidic residues: 30-36% are either aspartic or glutamic acid.

[edit] Structure

[edit] General structure

OPN is a highly negative charged, extracellular matrix protein that lacks an extensive secondary structure.^[2] It is composed of about 300 amino acids (297 in mouse; 314 in human) and is expressed as a 33-kDa nascent protein; there are also functionally important cleavage sites. OPN can go through posttranslational modifications which increase its apparent molecular weight to about 44 kDa.^[3]

Figure 1. Proteolytic cleavage sites for full length osteopontin (OPN-FL). Thrombin exposes the cleaved epitope SVVYGLR (OPN-R), and then CPB removes the c-terminal arginine from OPN-R. The cleaved epitope has a non-RGD domain, which binds to integrin receptors (α4β1, α9β1, and α9β4). Next to the cleaved epitope, there is a RGD domain which interacts with other integrin receptors (αvβ1,3,5, and α5β1).

[edit] Isoforms

Full length OPN (OPN-FL) can be modified by thrombin cleavage, which exposes a cryptic sequence, SVVYGLR on the cleaved form of the protein known as OPN-R (Fig. 1). This thrombin-cleaved OPN (OPN-R) exposes an epitope for integrin receptors of α4β1, α9β1, and α9β4.^[4][5] These integrin receptors are present on a number of immune cells such as mast cells,^[6] neutrophils,^[7] and T cells. It is also expressed by monocytes and macrophages.^[8] Upon binding these receptors, cells use several signal transduction pathways to elicit immune responses in these cells (See Section 3 for more detail). OPN-R can be further cleaved by Carboxypeptidase B (CPB) by removal of C-terminal arginine and become OPN-L (Fig. 2). The function of OPN-L is largely unknown.

[edit] Biosynthesis

Osteopontin is biosynthesized by a variety of tissue types including fibroblasts^[9] preosteoblasts, osteoblasts, osteocytes, odontoblasts, some bone marrow cells, hypertrophic chondrocytes, dendritic cells, macrophages,^[10] smooth muscle,^[11] skeletal muscle myoblasts,^[12] endothelial cells, and extraosseous(non-bone) cells in the inner ear, brain, kidney, deciduum, and placenta. Synthesis of osteopontin is stimulated by calcitriol (1,25-dihydroxy-vitamin D3).

[edit] Biological function

[edit] Role in bone remodeling

Osteopontin has been implicated as an important factor in bone remodeling.^[13] Specifically, research suggests it plays a role in anchoring osteoclasts to the mineral matrix of bones.^[6] The organic part of bone is about 20% of the dry weight, and counts in, other than osteopontin, collagen type I, osteocalcin, osteonectin, bone sialo protein and alkaline phosphatase. Collagen type I counts for 90% of the protein mass. The inorganic part of bone is the mineral hydroxyapatite, Ca₁₀(PO₄)₆(OH)₂. Loss of this mineral may leads to osteoporosis, as the bone is depleted for calcium if this is not supplied in the diet.

[edit] Role in immune functions

As discussed, OPN binds to several integrin receptors including α4β1, α9β1, and α9β4 expressed by leukocytes. These receptors have been well-established to function in cell adhesion, migration, and survival in these cells. Therefore, recent research efforts have focused on the role of OPN in mediating such responses.

Osteopontin (OPN) is expressed in a range of immune cells, including macrophages, neutrophils, dendritic cells, and T and B cells, with varying kinetics. OPN is reported in act as an immune modulator in a variety of manners.^[14] Firstly, it has chemotactic properties, which promote cell recruitment to inflammatory sites. It also functions as an adhesion protein, involved in cell attachment and wound healing. In addition, OPN mediates cell activation and cytokine production, as well as promoting cell survival by regulating apoptosis.^[14] The following examples are found.^[14]

[edit] Chemotaxis

OPN plays an important role in neutrophil recruitment in alcoholic liver disease.^[7][15] OPN is important for the migration of neutrophil in vitro.^[16] In addition, OPN recruits inflammatory cells to arthritis joints in the collagen-induced arthritis model of rheumatoid arthritis.^[17][18] A recent in vitro study in 2008 has found that OPN plays a role in mast cell migration.^[19] Here OPN knock-out mast cells were cultured and they observed a decreased level of chemotaxis in these cells compared to wildtype mast cells. OPN was also found to act as a macrophage chemotactic factor.^[20] In this study, researchers looked at the accumulation of macrophages in the brain of rhesus monkeys and found that OPN prevented macrophages from leaving the accumulation site, indicating an increased level of chemotaxis.

[edit] Cell activation

Activated T cells are promoted by IL-12 to differentiate towards the Th1 type, producing cytokines including IL-12 and IFNγ. OPN inhibits production of the Th2 cytokine IL-10, which leads to enhanced Th1 response. OPN influences cell-mediated immunity and has Th1 cytokine functions. It enhances B cell immunoglobulin production and proliferation.^[2] Recent studies in 2008 suggest that OPN also induces mast cell degranulation.^[19] The researchers here observed that IgE-mediated anaphylaxis was significantly reduced in OPN knock-out mice compared to wild type mice. The role of OPN in activation of macrophages has also been implicated in a cancer study, when researchers discovered that OPN-producing tumors were able to induce macrophage activation compared to OPN-deficient tumors.^[21]

Fig 2. Known immunologic functions of OPN. OPN binds to several integrin receptors including α4β1, α9β1, and α9β4 expressed by leukocytes and are known to induce cell adhesion, migration, and survival in immune cells including neutrophils, macrophages, T cells, mast cells, and osteoclasts.

[edit] Apoptosis

OPN is an important anti-apoptotic factor in many circumstances. OPN blocks the activation-induced cell death of macrophages and T cells as well as fibroblasts and endothelial cells exposed to harmful stimuli.^[22][23] OPN prevents non-programmed cell death in inflammatory colitis.^[24]

[edit] Potential clinical application

The fact that OPN interacts with multiple cell surface receptors which are ubiquitously expressed makes it an active player in many physiological and pathological processes including wound healing, bone turnover, tumorigenesis, inflammation, ischemia and immune responses1. Therefore, manipulation of plasma OPN levels may be useful in the treatment of autoimmune diseases, cancer metastasis, osteoporosis and some forms of stress.^[2]

[edit] Role in autoimmune diseases

OPN has been implicated in pathogenesis of rheumatoid arthritis. For instance, researchers found that OPN-R, the thrombin-cleaved form of OPN, was elevated in the rheumatoid arthritis joint16. However, the role of OPN in rheumatoid arthritis is still unclear. One group found that OPN knock-out mice were protected against arthritis.^[25] while others were not able to reproduce this observation^[26]. OPN has been found to play a role in other autoimmune diseases including autoimmune hepatitis, allergic airway disease, and multiple sclerosis.^[27]

[edit] Role in cancers and inflammatory diseases

It has been shown that OPN drives IL-17 production;^[28] OPN is overexpressed in a variety of cancers, including lung cancer, breast cancer, colorectal cancer, stomach cancer, ovarian cancer, melanoma and mesothelioma; OPN contributes both glomerulonephritis and tubulointerstitial nephritis; and OPN is found in atheromatous plaques within arteries. Thus, manipulation of plasma OPN levels may be useful in the treatment of autoimmune diseases, cancer metastasis, osteoporosis and some forms of stress.^[2]

Research has implicated osteopontin in excessive scar-forming and a gel has been developed to inhibit its effect.^[29]

[edit] References

[edit] Additional images

Osteoclast

[edit] Further reading

[edit] External links

• MeSH Osteopontin